Metropolis Labs sells out a stake to Carlyle Group unit

Published On 2015-09-10 13:10 GMT   |   Update On 2015-09-10 13:10 GMT

REUTERS - A unit of Carlyle Group LP has bought a stake in Metropolis Healthcare Ltd, the India-based global operator of pathology laboratories, for an undisclosed sum, according to a statement from the U.S. private equity firm on Wednesday.A source familiar with the matter told Reuters that Carlyle's investment was about $150 million to $200 million  (Rs.900-1300 crore). The source did...

Login or Register to read the full article
REUTERS - A unit of Carlyle Group LP has bought a stake in Metropolis Healthcare Ltd, the India-based global operator of pathology laboratories, for an undisclosed sum, according to a statement from the U.S. private equity firm on Wednesday.

A source familiar with the matter told Reuters that Carlyle's investment was about $150 million to $200 million  (Rs.900-1300 crore). The source did not disclose the size of the stake, although other sources specify it to be around 37 percent stake in the company.

An affiliate of buyout fund Carlyle Asia Partners IV bought the stake in Metropolis from former promoter Dr GSK Velu and his affiliates, according to the statement.

Metropolis runs laboratories in India, Sri Lanka, the United Arab Emirates, and countries in Africa including South Africa and Kenya. It operates a network of 130 laboratories with more than 1000 centres in India

 

 
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News